Olema Pharmaceuticals (OLMA) Short Interest Ratio & Short Volume $6.41 -0.61 (-8.69%) Closing price 04:00 PM EasternExtended Trading$6.40 -0.02 (-0.23%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Olema Pharmaceuticals Short Interest OverviewAs of September 30, 2026, Olema Pharmaceuticals (OLMA) had a short interest of 14.70 million shares sold short, representing 19.21% of the public float. This marks a -8.54% decrease in short interest since the prior report. The short interest ratio (days to cover) is 10.2, meaning it would take 10.2 days of the average trading volume of 1.37 million shares to cover all short positions.Current Short Interest14,696,219 sharesPrevious Short Interest16,068,469 sharesChange Vs. Previous Month-8.54%Dollar Volume Sold Short$126.98 millionShort Interest Ratio10.2 Days to CoverLast Record DateSeptember 30, 2026Outstanding Shares87,500,000 sharesShort Percent of Float19.21%Today's Trading Volume1,984,562 sharesAverage Trading Volume1,372,144 sharesToday's Volume Vs. Average145% Short Selling Olema Pharmaceuticals? Sign up to receive the latest short interest report for Olema Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOLMA Short Interest Over TimeOLMA Days to Cover Over TimeOLMA Percentage of Float Shorted Over Time Olema Pharmaceuticals Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/202614,696,219 shares $126.98 million -8.5%19.2%10.19 $8.64 9/15/202616,068,469 shares $157.15 million +2.6%21.0%15.93 $9.78 8/31/202615,663,548 shares $163.37 million -0.9%20.5%18.54 $10.43 8/14/202615,808,921 shares $168.05 million -1.0%20.7%14.25 $10.63 7/31/202615,963,215 shares $182.78 million +5.7%20.9%18.21 $11.45 7/15/202615,101,848 shares $178.50 million +7.6%19.8%11.29 $11.82 6/30/202614,033,964 shares $175.56 million +9.3%18.4%5.68 $12.51 6/15/202612,843,113 shares $126.89 million +7.7%16.8%7.88 $9.88 5/29/202611,927,602 shares $157.33 million +2.9%15.6%10.53 $13.19 5/15/202611,587,581 shares $157.48 million -11.2%15.2%10.24 $13.59 Get the Latest News and Ratings for OLMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/30/202613,041,205 shares $187.92 million +0.8%17.1%16.48 $14.41 4/15/202612,934,118 shares $213.28 million +5.5%16.9%14.57 $16.49 3/31/202612,265,390 shares $182.88 million +48.8%16.1%6.3 $14.91 3/13/20268,240,774 shares $121.22 million -0.2%11.3%2.96 $14.71 2/27/20268,257,215 shares $199.82 million -8.3%14.4%7.48 $24.20 2/13/20269,002,172 shares $203.36 million -11.0%11.8%5.71 $22.59 1/30/202610,111,842 shares $260.08 million +11.1%17.6%10.99 $25.72 1/15/20269,100,561 shares $265.65 million -12.5%15.8%6.27 $29.19 12/31/202510,399,087 shares $259.98 million -6.2%18.1%5.19 $25.00 12/15/202511,090,858 shares $397.39 million +2.6%19.3%3.48 $35.83 11/28/202510,810,748 shares $303.57 million +15.5%18.8%0.75 $28.08 11/14/20259,364,250 shares $78.66 million +11.9%16.3%9.95 $8.40 10/31/20258,366,665 shares $75.05 million +10.9%14.6%5.14 $8.97 10/15/20257,550,000 shares $78.29 million -3.1%13.2%6.9 $10.37 9/30/20257,790,000 shares $76.26 million -5.5%N/A9.2 $9.79 9/15/20258,240,000 shares $65.92 million -2.0%N/A10.4 $8.00 8/31/20258,410,000 shares $45.92 million -0.8%14.7%11.1 $5.46 8/15/20258,480,000 shares $46.72 million +11.0%N/A12.7 $5.51 7/31/20257,640,000 shares $39.27 million No Change13.4%11.3 $5.14 7/15/20257,640,000 shares $35.07 million -6.3%N/A10.1 $4.59 6/30/20258,150,000 shares $34.72 million +21.6%14.2%9.5 $4.26 6/15/20256,700,000 shares $27.94 million +6.4%11.7%7.3 $4.17 5/31/20256,300,000 shares $33.52 million +6.8%13.6%6.8 $5.32 5/15/20255,900,000 shares $27.67 million +8.7%12.8%6.5 $4.69 4/30/20255,430,000 shares $28.02 million -10.7%N/A5.7 $5.16 4/15/20256,080,000 shares $25.60 million -6.5%13.2%6.1 $4.21 3/31/20256,500,000 shares $24.44 million -25.2%14.1%6 $3.76 3/15/20258,690,000 shares $38.32 million +2.6%18.8%8 $4.41 2/28/20258,470,000 shares $37.01 million +3.0%18.3%7.5 $4.37 2/15/20258,220,000 shares $40.85 million -2.3%17.8%7.5 $4.97The $15 Gold Fund That Pays Up to $1,152/Month (Ad)Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.Discover the gold income fund before the next payout date 1/31/20258,410,000 shares $51.39 million -22.6%N/A7.9 $6.11 1/15/202510,870,000 shares $60.00 million +4.5%N/A11.5 $5.52 12/31/202410,400,000 shares $60.63 million +4.3%N/A12.8 $5.83 12/15/20249,970,000 shares $67.30 million -0.5%N/A14.9 $6.75 11/30/202410,020,000 shares $101.40 million +17.1%N/A19.5 $10.12 11/15/20248,560,000 shares $78.50 million +3.0%N/A17.6 $9.17 10/31/20248,310,000 shares $95.81 million -2.2%N/A17.9 $11.53 10/15/20248,500,000 shares $99.03 million -0.1%N/A15.8 $11.65 9/30/20248,510,000 shares $101.61 million -3.6%N/A14.2 $11.94 9/15/20248,830,000 shares $112.14 million -0.1%N/A13.4 $12.70 8/31/20248,840,000 shares $104.31 million +3.0%N/A12.7 $11.80 8/15/20248,580,000 shares $106.31 million +6.7%N/A9.2 $12.39 7/31/20248,040,000 shares $129.93 million +10.0%N/A8.3 $16.16 7/15/20247,310,000 shares $96.05 million +14.6%N/A7.7 $13.14 6/30/20246,380,000 shares $69.03 million -18.0%N/A6.8 $10.82 6/15/20247,780,000 shares $96.16 million -4.8%N/A8.4 $12.36 5/31/20248,170,000 shares $79.09 million -4.3%N/A7.9 $9.68 5/15/20248,540,000 shares $84.12 million +1.7%N/A10.4 $9.85 4/30/20248,400,000 shares $85.43 million -6.4%N/A10.5 $10.17 4/15/20248,970,000 shares $97.32 million +10.7%N/A11.1 $10.85 3/31/20248,100,000 shares $91.69 million +60.1%N/A9.9 $11.32 3/15/20245,060,000 shares $58.44 million +3.9%N/A6.4 $11.55 2/29/20244,870,000 shares $60.39 million -21.2%N/A5.9 $12.40 2/15/20246,180,000 shares $91.53 million -7.9%N/A6.8 $14.81 1/31/20246,710,000 shares $87.50 million -5.2%N/A7.5 $13.04 1/15/20247,080,000 shares $82.13 million +0.7%N/A8.3 $11.60 12/31/20237,030,000 shares $98.63 million +5.7%N/A8.5 $14.03 12/15/20236,650,000 shares $81.13 million +27.6%N/A8.5 $12.20 11/30/20235,210,000 shares $72.68 million +88.8%N/A8.1 $13.95 11/15/20232,760,000 shares $46.42 million No ChangeN/A6.4 $16.82 10/31/20232,760,000 shares $36.68 million +26.0%7.3%7.9 $13.29 10/15/20232,190,000 shares $27.66 million +10.6%5.8%7.6 $12.63 9/30/20231,980,000 shares $24.45 million +12.5%5.4%7.1 $12.35 9/15/20231,760,000 shares $22.69 million +10.7%4.8%5.9 $12.89 8/31/20231,590,000 shares $16.14 million -9.7%4.4%4.1 $10.15 8/15/20231,760,000 shares $19.03 million -4.4%5.0%4.8 $10.81 7/31/20231,840,000 shares $15.92 million -4.7%5.3%5.1 $8.65 7/15/20231,930,000 shares $15.81 million +5.5%5.6%5.4 $8.19 6/30/20231,830,000 shares $16.52 million +55.1%5.3%5 $9.03 6/15/20231,180,000 shares $10.71 million +14.6%3.4%3.7 $9.08 5/31/20231,030,000 shares $5.33 million No Change3.0%5.2 $5.17 5/15/20231,030,000 shares $6.89 million +1.0%3.0%6.2 $6.69 4/30/20231,020,000 shares $4.89 million -6.4%3.0%6 $4.79 4/15/20231,090,000 shares $3.99 million -4.4%3.2%6.5 $3.66 3/31/20231,140,000 shares $3.96 million +3.6%3.3%6.3 $3.47 3/15/20231,100,000 shares $4.38 million -1.8%3.2%7.5 $3.98 2/28/20231,120,000 shares $4.59 million -21.1%3.3%7.5 $4.10 2/15/20231,420,000 shares $6.38 million No Change4.1%9.1 $4.49 1/31/20231,420,000 shares $6.86 million -7.2%4.1%8.7 $4.83 1/15/20231,530,000 shares $6.35 million +1.3%4.5%10.3 $4.15The end may be near for these iconic stocks (Ad)Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.Watch Marc Chaikin's free presentation and get his full buy-and-sell list today 12/30/20221,510,000 shares $3.70 million -5.6%4.4%12.5 $2.45 12/15/20221,600,000 shares $3.92 million +1.3%4.7%12.3 $2.45 11/30/20221,580,000 shares $4.53 million -3.1%4.6%10.7 $2.87 11/15/20221,630,000 shares $5.22 million +4.5%4.7%10.2 $3.20 10/31/20221,560,000 shares $5.87 million +3.3%4.5%8 $3.76 10/15/20221,510,000 shares $4.32 million -3.2%4.4%7.3 $2.86 9/30/20221,560,000 shares $4.31 million -7.1%4.5%4.7 $2.76 9/15/20221,680,000 shares $6.89 million -6.2%4.9%4.2 $4.10 8/31/20221,790,000 shares $7.07 million -6.3%5.2%4 $3.95 8/15/20221,910,000 shares $8.16 million +6.1%5.6%3.7 $4.27 7/31/20221,800,000 shares $9.04 million +0.6%5.2%3.4 $5.02 7/15/20221,790,000 shares $8.41 million -14.8%5.2%3.3 $4.70 6/30/20222,100,000 shares $8.55 million -23.6%6.1%4.6 $4.07 6/15/20222,750,000 shares $10.20 million +10.9%8.1%6 $3.71 5/31/20222,480,000 shares $7.09 million -9.5%7.3%5.9 $2.86 5/15/20222,740,000 shares $5.92 million +1.5%8.1%6.9 $2.16 4/30/20222,700,000 shares $6.89 million +13.5%8.1%7.2 $2.55 4/15/20222,380,000 shares $7.33 million -18.2%7.2%5.7 $3.08 3/31/20222,910,000 shares $12.40 million +1.8%8.8%6.9 $4.26 3/15/20222,860,000 shares $11.13 million -5.0%8.6%6.3 $3.89 2/28/20223,010,000 shares $14.09 million +14.5%9.1%5.9 $4.68 2/15/20222,630,000 shares $13.47 million +0.8%7.9%3.1 $5.12 1/31/20222,610,000 shares $16.78 million +8.8%8.2%3.1 $6.43 1/15/20222,400,000 shares $16.06 million -37.5%7.6%3 $6.69 12/31/20213,840,000 shares $35.94 million +15.0%12.1%4.7 $9.36 12/15/20213,340,000 shares $30.69 million -17.9%10.5%4.2 $9.19 11/30/20214,070,000 shares $35.61 million +23.0%12.9%5.4 $8.75 11/15/20213,310,000 shares $87.02 million +22.6%10.5%8.6 $26.29 10/29/20212,700,000 shares $72.90 million +16.4%8.7%8 $27.00 OLMA Short Interest - Frequently Asked Questions What is Olema Pharmaceuticals' current short interest? Short interest is the volume of Olema Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 14,696,219 shares of OLMA short. 19.21% of Olema Pharmaceuticals' shares are currently sold short. Learn More on Olema Pharmaceuticals' current short interest. What is a good short interest ratio for Olema Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OLMA shares currently have a short interest ratio of 10.2. Learn More on Olema Pharmaceuticals's short interest ratio. What is a good short interest percentage for Olema Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.21% of Olema Pharmaceuticals' floating shares are currently sold short. Is Olema Pharmaceuticals' short interest increasing or decreasing? Olema Pharmaceuticals saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 14,696,219 shares, a drop of 8.5% from the previous total of 16,068,469 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Olema Pharmaceuticals' short interest compare to its competitors? 19.21% of Olema Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Olema Pharmaceuticals: Beam Therapeutics Inc. (27.73%), NewAmsterdam Pharma Company N.V. (18.26%), Viridian Therapeutics, Inc. (16.25%), ADMA Biologics Inc (9.57%), Precigen, Inc. (22.76%), Celldex Therapeutics, Inc. (14.78%), SELLAS Life Sciences Group, Inc. (27.66%), Aurinia Pharmaceuticals Inc (6.64%), Vera Therapeutics, Inc. (28.45%), Agios Pharmaceuticals, Inc. (12.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks. What does it mean to sell short Olema Pharmaceuticals stock? Short selling OLMA is an investing strategy that aims to generate trading profit from Olema Pharmaceuticals as its price is falling. OLMA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Olema Pharmaceuticals? A short squeeze for Olema Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OLMA, which in turn drives the price of the stock up even further. How often is Olema Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OLMA, twice per month. The most recent reporting period available is September, 30 2026. What do OLMA's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like OLMA:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies BEAM Short Squeeze NAMS Short Squeeze VRDN Short Squeeze ADMA Short Squeeze PGEN Short Squeeze CLDX Short Squeeze SLS Short Squeeze AUPH Short Squeeze VERA Short Squeeze AGIO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates Short interest data for NASDAQ:OLMA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olema Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olema Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
